nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Muscle strain—Metformin—polycystic ovary syndrome	0.0565	0.164	CcSEcCtD
Etoricoxib—Angina unstable—Metformin—polycystic ovary syndrome	0.0281	0.0815	CcSEcCtD
Etoricoxib—PTGS2—ovarian follicle—polycystic ovary syndrome	0.027	0.127	CbGeAlD
Etoricoxib—CYP2C19—urine—polycystic ovary syndrome	0.0167	0.0786	CbGeAlD
Etoricoxib—Sinus congestion—Metformin—polycystic ovary syndrome	0.0142	0.0414	CcSEcCtD
Etoricoxib—CYP1A2—urine—polycystic ovary syndrome	0.0136	0.0642	CbGeAlD
Etoricoxib—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0135	0.0391	CcSEcCtD
Etoricoxib—CYP2C9—urine—polycystic ovary syndrome	0.0129	0.061	CbGeAlD
Etoricoxib—MAPK14—embryo—polycystic ovary syndrome	0.0127	0.0598	CbGeAlD
Etoricoxib—CYP2E1—urine—polycystic ovary syndrome	0.0122	0.0578	CbGeAlD
Etoricoxib—Toothache—Metformin—polycystic ovary syndrome	0.0116	0.0338	CcSEcCtD
Etoricoxib—Heartburn—Metformin—polycystic ovary syndrome	0.0103	0.0299	CcSEcCtD
Etoricoxib—CYP3A4—urine—polycystic ovary syndrome	0.00986	0.0465	CbGeAlD
Etoricoxib—CYP2D6—urine—polycystic ovary syndrome	0.0097	0.0457	CbGeAlD
Etoricoxib—Fungal infection—Metformin—polycystic ovary syndrome	0.00918	0.0267	CcSEcCtD
Etoricoxib—MAPK14—uterus—polycystic ovary syndrome	0.00855	0.0403	CbGeAlD
Etoricoxib—MAPK14—pituitary gland—polycystic ovary syndrome	0.0084	0.0396	CbGeAlD
Etoricoxib—MAPK14—adipose tissue—polycystic ovary syndrome	0.00836	0.0394	CbGeAlD
Etoricoxib—Contusion—Metformin—polycystic ovary syndrome	0.00812	0.0236	CcSEcCtD
Etoricoxib—MAPK14—adrenal gland—polycystic ovary syndrome	0.0075	0.0354	CbGeAlD
Etoricoxib—MAPK14—female gonad—polycystic ovary syndrome	0.00699	0.033	CbGeAlD
Etoricoxib—MAPK14—vagina—polycystic ovary syndrome	0.00695	0.0328	CbGeAlD
Etoricoxib—Neuropathy—Metformin—polycystic ovary syndrome	0.00665	0.0193	CcSEcCtD
Etoricoxib—MAPK14—endocrine gland—polycystic ovary syndrome	0.0065	0.0307	CbGeAlD
Etoricoxib—Injury—Metformin—polycystic ovary syndrome	0.0056	0.0163	CcSEcCtD
Etoricoxib—Renal impairment—Metformin—polycystic ovary syndrome	0.00541	0.0157	CcSEcCtD
Etoricoxib—Pain in extremity—Metformin—polycystic ovary syndrome	0.00514	0.0149	CcSEcCtD
Etoricoxib—Breast disorder—Metformin—polycystic ovary syndrome	0.00465	0.0135	CcSEcCtD
Etoricoxib—Cramp muscle—Metformin—polycystic ovary syndrome	0.00463	0.0135	CcSEcCtD
Etoricoxib—Abdominal distension—Metformin—polycystic ovary syndrome	0.00448	0.013	CcSEcCtD
Etoricoxib—Pancreatitis—Metformin—polycystic ovary syndrome	0.00436	0.0127	CcSEcCtD
Etoricoxib—Angina pectoris—Metformin—polycystic ovary syndrome	0.00433	0.0126	CcSEcCtD
Etoricoxib—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00426	0.0124	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00413	0.012	CcSEcCtD
Etoricoxib—Infestation NOS—Metformin—polycystic ovary syndrome	0.00396	0.0115	CcSEcCtD
Etoricoxib—Infestation—Metformin—polycystic ovary syndrome	0.00396	0.0115	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00389	0.0113	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00375	0.0109	CcSEcCtD
Etoricoxib—PTGS2—embryo—polycystic ovary syndrome	0.00365	0.0172	CbGeAlD
Etoricoxib—Hepatitis—Metformin—polycystic ovary syndrome	0.00356	0.0103	CcSEcCtD
Etoricoxib—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00354	0.0103	CcSEcCtD
Etoricoxib—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00351	0.0102	CcSEcCtD
Etoricoxib—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0035	0.0102	CcSEcCtD
Etoricoxib—Eye disorder—Metformin—polycystic ovary syndrome	0.00333	0.00966	CcSEcCtD
Etoricoxib—Flushing—Metformin—polycystic ovary syndrome	0.0033	0.00959	CcSEcCtD
Etoricoxib—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0033	0.00959	CcSEcCtD
Etoricoxib—Angiopathy—Metformin—polycystic ovary syndrome	0.00323	0.00938	CcSEcCtD
Etoricoxib—Immune system disorder—Metformin—polycystic ovary syndrome	0.00321	0.00934	CcSEcCtD
Etoricoxib—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00321	0.00931	CcSEcCtD
Etoricoxib—Malnutrition—Metformin—polycystic ovary syndrome	0.0031	0.009	CcSEcCtD
Etoricoxib—Erythema—Metformin—polycystic ovary syndrome	0.0031	0.009	CcSEcCtD
Etoricoxib—Flatulence—Metformin—polycystic ovary syndrome	0.00305	0.00887	CcSEcCtD
Etoricoxib—Dysgeusia—Metformin—polycystic ovary syndrome	0.00303	0.00881	CcSEcCtD
Etoricoxib—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00299	0.0141	CbGeAlD
Etoricoxib—Muscle spasms—Metformin—polycystic ovary syndrome	0.00298	0.00865	CcSEcCtD
Etoricoxib—CYP2C19—vagina—polycystic ovary syndrome	0.00295	0.0139	CbGeAlD
Etoricoxib—Vision blurred—Metformin—polycystic ovary syndrome	0.00292	0.00848	CcSEcCtD
Etoricoxib—Tremor—Metformin—polycystic ovary syndrome	0.0029	0.00843	CcSEcCtD
Etoricoxib—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00276	0.013	CbGeAlD
Etoricoxib—Palpitations—Metformin—polycystic ovary syndrome	0.00274	0.00795	CcSEcCtD
Etoricoxib—Hypertension—Metformin—polycystic ovary syndrome	0.00267	0.00777	CcSEcCtD
Etoricoxib—PTGS2—endometrium—polycystic ovary syndrome	0.00267	0.0126	CbGeAlD
Etoricoxib—Chest pain—Metformin—polycystic ovary syndrome	0.00264	0.00766	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00262	0.00761	CcSEcCtD
Etoricoxib—Oedema—Metformin—polycystic ovary syndrome	0.00253	0.00734	CcSEcCtD
Etoricoxib—Infection—Metformin—polycystic ovary syndrome	0.00251	0.00729	CcSEcCtD
Etoricoxib—Shock—Metformin—polycystic ovary syndrome	0.00249	0.00722	CcSEcCtD
Etoricoxib—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00248	0.0072	CcSEcCtD
Etoricoxib—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00248	0.00719	CcSEcCtD
Etoricoxib—PTGS2—uterus—polycystic ovary syndrome	0.00246	0.0116	CbGeAlD
Etoricoxib—Skin disorder—Metformin—polycystic ovary syndrome	0.00246	0.00713	CcSEcCtD
Etoricoxib—PTGS2—pituitary gland—polycystic ovary syndrome	0.00241	0.0114	CbGeAlD
Etoricoxib—Anorexia—Metformin—polycystic ovary syndrome	0.00241	0.007	CcSEcCtD
Etoricoxib—PTGS2—adipose tissue—polycystic ovary syndrome	0.0024	0.0113	CbGeAlD
Etoricoxib—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00234	0.011	CbGeAlD
Etoricoxib—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0023	0.00669	CcSEcCtD
Etoricoxib—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00226	0.0106	CbGeAlD
Etoricoxib—Dyspnoea—Metformin—polycystic ovary syndrome	0.00225	0.00655	CcSEcCtD
Etoricoxib—Somnolence—Metformin—polycystic ovary syndrome	0.00225	0.00653	CcSEcCtD
Etoricoxib—Dyspepsia—Metformin—polycystic ovary syndrome	0.00223	0.00646	CcSEcCtD
Etoricoxib—Decreased appetite—Metformin—polycystic ovary syndrome	0.0022	0.00638	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00218	0.00634	CcSEcCtD
Etoricoxib—Fatigue—Metformin—polycystic ovary syndrome	0.00218	0.00633	CcSEcCtD
Etoricoxib—Constipation—Metformin—polycystic ovary syndrome	0.00216	0.00628	CcSEcCtD
Etoricoxib—PTGS2—adrenal gland—polycystic ovary syndrome	0.00216	0.0102	CbGeAlD
Etoricoxib—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00214	0.0101	CbGeAlD
Etoricoxib—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00208	0.00605	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00207	0.006	CcSEcCtD
Etoricoxib—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00203	0.00958	CbGeAlD
Etoricoxib—PTGS2—female gonad—polycystic ovary syndrome	0.00201	0.00949	CbGeAlD
Etoricoxib—Urticaria—Metformin—polycystic ovary syndrome	0.00201	0.00583	CcSEcCtD
Etoricoxib—PTGS2—vagina—polycystic ovary syndrome	0.002	0.00943	CbGeAlD
Etoricoxib—Abdominal pain—Metformin—polycystic ovary syndrome	0.002	0.0058	CcSEcCtD
Etoricoxib—PTGS2—endocrine gland—polycystic ovary syndrome	0.00187	0.00882	CbGeAlD
Etoricoxib—Asthenia—Metformin—polycystic ovary syndrome	0.00181	0.00527	CcSEcCtD
Etoricoxib—Pruritus—Metformin—polycystic ovary syndrome	0.00179	0.0052	CcSEcCtD
Etoricoxib—Diarrhoea—Metformin—polycystic ovary syndrome	0.00173	0.00502	CcSEcCtD
Etoricoxib—CYP2D6—female gonad—polycystic ovary syndrome	0.00173	0.00816	CbGeAlD
Etoricoxib—Dizziness—Metformin—polycystic ovary syndrome	0.00167	0.00486	CcSEcCtD
Etoricoxib—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00163	0.00771	CbGeAlD
Etoricoxib—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00161	0.00759	CbGeAlD
Etoricoxib—Vomiting—Metformin—polycystic ovary syndrome	0.00161	0.00467	CcSEcCtD
Etoricoxib—Rash—Metformin—polycystic ovary syndrome	0.00159	0.00463	CcSEcCtD
Etoricoxib—Dermatitis—Metformin—polycystic ovary syndrome	0.00159	0.00463	CcSEcCtD
Etoricoxib—Headache—Metformin—polycystic ovary syndrome	0.00158	0.0046	CcSEcCtD
Etoricoxib—Nausea—Metformin—polycystic ovary syndrome	0.0015	0.00436	CcSEcCtD
Etoricoxib—PTGS2—Metabolism—LHB—polycystic ovary syndrome	8.63e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—BCL2—polycystic ovary syndrome	8.6e-05	0.000194	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	8.48e-05	0.000191	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—polycystic ovary syndrome	8.47e-05	0.000191	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	8.47e-05	0.000191	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	8.44e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NCOR1—polycystic ovary syndrome	8.39e-05	0.000189	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—polycystic ovary syndrome	8.32e-05	0.000187	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	8.32e-05	0.000187	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	8.32e-05	0.000187	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NRG1—polycystic ovary syndrome	8.28e-05	0.000187	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GAB1—polycystic ovary syndrome	8.27e-05	0.000186	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKR1C3—polycystic ovary syndrome	8.24e-05	0.000186	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	8.23e-05	0.000185	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	8.17e-05	0.000184	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	8.15e-05	0.000184	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	8.13e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.12e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.12e-05	0.000183	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.11e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	8.09e-05	0.000182	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NAMPT—polycystic ovary syndrome	8.06e-05	0.000182	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PGR—polycystic ovary syndrome	8.03e-05	0.000181	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	8e-05	0.00018	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.99e-05	0.00018	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	7.94e-05	0.000179	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.87e-05	0.000177	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—polycystic ovary syndrome	7.8e-05	0.000176	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	7.8e-05	0.000176	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR3C1—polycystic ovary syndrome	7.76e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	7.73e-05	0.000174	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	7.69e-05	0.000173	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	7.55e-05	0.00017	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.52e-05	0.00017	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	7.52e-05	0.00017	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	7.51e-05	0.000169	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PLAT—polycystic ovary syndrome	7.46e-05	0.000168	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GHRL—polycystic ovary syndrome	7.46e-05	0.000168	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	7.44e-05	0.000168	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	7.4e-05	0.000167	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.37e-05	0.000166	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.29e-05	0.000164	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	7.29e-05	0.000164	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—polycystic ovary syndrome	7.28e-05	0.000164	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	7.21e-05	0.000162	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—polycystic ovary syndrome	7.15e-05	0.000161	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ATF1—polycystic ovary syndrome	7.12e-05	0.00016	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRS2—polycystic ovary syndrome	7.09e-05	0.00016	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—polycystic ovary syndrome	7.09e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	7.08e-05	0.00016	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	7.02e-05	0.000158	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.97e-05	0.000157	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.94e-05	0.000156	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	6.88e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	6.86e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.8e-05	0.000153	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	6.75e-05	0.000152	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.71e-05	0.000151	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	6.66e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	6.63e-05	0.000149	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.62e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	6.61e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	6.61e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.57e-05	0.000148	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGFR—polycystic ovary syndrome	6.57e-05	0.000148	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRL—polycystic ovary syndrome	6.51e-05	0.000147	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.44e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.42e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.42e-05	0.000145	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	6.35e-05	0.000143	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	6.33e-05	0.000143	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	6.33e-05	0.000143	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	6.3e-05	0.000142	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	6.29e-05	0.000142	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	6.27e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.27e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.27e-05	0.000141	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.23e-05	0.00014	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	6.23e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.2e-05	0.00014	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	6.19e-05	0.00014	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IRS1—polycystic ovary syndrome	6.19e-05	0.00014	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.18e-05	0.000139	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	6.13e-05	0.000138	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—polycystic ovary syndrome	6.01e-05	0.000136	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRL—polycystic ovary syndrome	5.94e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	5.94e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	5.92e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.88e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	5.83e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	5.77e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT2—polycystic ovary syndrome	5.73e-05	0.000129	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GNAS—polycystic ovary syndrome	5.73e-05	0.000129	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.72e-05	0.000129	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	5.64e-05	0.000127	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	5.62e-05	0.000127	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.59e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.46e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	5.46e-05	0.000123	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.46e-05	0.000123	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SERPINE1—polycystic ovary syndrome	5.42e-05	0.000122	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.41e-05	0.000122	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.38e-05	0.000121	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TH—polycystic ovary syndrome	5.36e-05	0.000121	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	5.36e-05	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NRG1—polycystic ovary syndrome	5.36e-05	0.000121	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.3e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.29e-05	0.000119	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	5.21e-05	0.000118	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5.1e-05	0.000115	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.1e-05	0.000115	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TH—polycystic ovary syndrome	5.05e-05	0.000114	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—polycystic ovary syndrome	5.04e-05	0.000114	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	5.02e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.02e-05	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BCL2—polycystic ovary syndrome	5.01e-05	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.98e-05	0.000112	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NCOR1—polycystic ovary syndrome	4.98e-05	0.000112	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	4.91e-05	0.000111	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	4.9e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.9e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	4.89e-05	0.00011	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NRG1—polycystic ovary syndrome	4.89e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.87e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	4.87e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.86e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.84e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.82e-05	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.8e-05	0.000108	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.78e-05	0.000108	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	4.69e-05	0.000106	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.65e-05	0.000105	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.63e-05	0.000104	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	4.61e-05	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS2—polycystic ovary syndrome	4.59e-05	0.000103	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.57e-05	0.000103	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.51e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.5e-05	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—polycystic ovary syndrome	4.49e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.47e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4.45e-05	0.0001	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—polycystic ovary syndrome	4.45e-05	0.0001	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.44e-05	0.0001	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.41e-05	9.95e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—polycystic ovary syndrome	4.4e-05	9.91e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.38e-05	9.87e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	4.38e-05	9.86e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.33e-05	9.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.26e-05	9.6e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.2e-05	9.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS2—polycystic ovary syndrome	4.18e-05	9.43e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	4.17e-05	9.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.17e-05	9.39e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.14e-05	9.33e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.14e-05	9.32e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	4.12e-05	9.29e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	4.12e-05	9.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.1e-05	9.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IRS1—polycystic ovary syndrome	4e-05	9.03e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	3.97e-05	8.96e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	3.95e-05	8.91e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	3.92e-05	8.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.89e-05	8.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—polycystic ovary syndrome	3.86e-05	8.69e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—INS—polycystic ovary syndrome	3.83e-05	8.64e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.82e-05	8.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.8e-05	8.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.79e-05	8.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.77e-05	8.5e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.77e-05	8.5e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.74e-05	8.44e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	3.72e-05	8.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—polycystic ovary syndrome	3.71e-05	8.36e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT2—polycystic ovary syndrome	3.71e-05	8.35e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.69e-05	8.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	3.68e-05	8.3e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IRS1—polycystic ovary syndrome	3.65e-05	8.23e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.58e-05	8.07e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.57e-05	8.05e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.56e-05	8.03e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.56e-05	8.03e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.55e-05	8e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.52e-05	7.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.51e-05	7.9e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—INS—polycystic ovary syndrome	3.5e-05	7.89e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.48e-05	7.85e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	3.47e-05	7.82e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.45e-05	7.78e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT2—polycystic ovary syndrome	3.38e-05	7.62e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.29e-05	7.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.27e-05	7.38e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.25e-05	7.32e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	3.21e-05	7.24e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.18e-05	7.17e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.18e-05	7.16e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.07e-05	6.91e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.03e-05	6.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.03e-05	6.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	2.99e-05	6.73e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.95e-05	6.65e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.95e-05	6.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—polycystic ovary syndrome	2.95e-05	6.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—INS—polycystic ovary syndrome	2.93e-05	6.6e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.92e-05	6.59e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.91e-05	6.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.9e-05	6.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.87e-05	6.47e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	2.81e-05	6.34e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.78e-05	6.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.77e-05	6.25e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.77e-05	6.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.76e-05	6.22e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2.76e-05	6.22e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.75e-05	6.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.71e-05	6.1e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.68e-05	6.03e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.64e-05	5.95e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.62e-05	5.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—polycystic ovary syndrome	2.59e-05	5.84e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.48e-05	5.58e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.46e-05	5.55e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.44e-05	5.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.42e-05	5.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.36e-05	5.32e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.34e-05	5.28e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.28e-05	5.13e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.24e-05	5.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.17e-05	4.89e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.14e-05	4.83e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.14e-05	4.82e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.13e-05	4.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.08e-05	4.7e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2e-05	4.5e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.98e-05	4.46e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.97e-05	4.44e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.96e-05	4.41e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.95e-05	4.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.94e-05	4.37e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.91e-05	4.31e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.82e-05	4.1e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.73e-05	3.89e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.69e-05	3.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—polycystic ovary syndrome	1.68e-05	3.78e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.67e-05	3.76e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.66e-05	3.74e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.61e-05	3.63e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—polycystic ovary syndrome	1.53e-05	3.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.3e-05	2.94e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.29e-05	2.9e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.28e-05	2.88e-05	CbGpPWpGaD
